Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS study

Hellenic J Cardiol. 2023 Sep 18:S1109-9666(23)00153-7. doi: 10.1016/j.hjc.2023.09.003. Online ahead of print.NO ABSTRACTPMID:37730147 | DOI:10.1016/j.hjc.2023.09.003

Source: Hellenic Journal of Cardiology - September 20, 2023 Category: Cardiology Authors: C Vlachopoulos D Massia G Kochiadakis G Kolovou S Patsilinakos I Bridges M Sibartie N N Dhalwani E Liberopoulos K K Ray Source Type: research